Specifically, Liu et al. demonstrated that in SR RCC, NFAT1 is stabilized via PI3K/AKT/GSK-3β signaling and FOXA1/SETD2-mediated downregulation of FBW7, leading to increased PD-L1 expression. The gene discussed is AKT1; the disease is renal cell adenocarcinoma.